One question from Legal & General America includes inquiring about any recent significant weight loss to mitigate this risk, though practices may evolve as data on GLP-1 use accumulates
A similar subtle gray matter pathology has also been described in the MS brain
By keeping food in the stomach longer, these medications help patients feel satisfied with smaller portions and experience more gradual rises in blood glucose after meals
Its best to start with a small dose of melatonin, and speak with your healthcare provider if youre interested in increasing your dose of melatonin
1 Introduction Metabolic dysfunction-associated steatohepatitis (MASH), previously termed non-alcoholic steatohepatitis, has become the most common cause of chronic liver disease worldwide, mirroring the rise in obesity and type 2 diabetes mellitus (T2DM) ( At the mechanistic level, MASH develops through coordinated dysfunction among hepatocytes, Kupffer cells, and hepatic stellate cells (HSCs) ( Figure 1 )